Tandutinib
| CAS No. | 387867-13-2 |
|---|---|
| MDL No. | MFCD09954147 |
| MF | C31H42N6O4 |
| MW | 562.70 |
| InChI Key | UXXQOJXBIDBUAC-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Tandutinib is an N-arylpiperazine with a 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl group at position 1 and a (p-isopropoxyphenyl)aminocarbonyl group at position 4. It inhibits tyrosine kinases FLT3, PDGFR, and KIT. Tandutinib functions as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is classified as an N-carbamoylpiperazine, a member of quinazolines, piperidines, aromatic ethers, tertiary amines, and phenylureas.
| CAS No. | 387867-13-2 |
|---|---|
| Product Name | Tandutinib |
Biological Targets
PDGFRB·KIT·FLT3
Associated Conditions
gliosarcoma·renal cell carcinoma·anaplastic oligodendroglioma·anaplastic astrocytoma·acute myeloid leukemia·
* The information provided here is compiled from public sources and is for reference only.